Ms. Brigitte Zirger at the Industry, Science and Technology Committee

On October 7th, 2010. See this statement in context.

October 7th, 2010 / 12:25 p.m.

Director, Policy Bureau, Therapeutic Products Directorate, Health Products and Food Branch, Department of Health

No. The mandatory review is if the Commissioner of Patents receives a request for a compulsory licence under CAMR. Then the Commissioner of Patents will turn to Health Canada and ask if it meets the requirements of the Food and Drugs Act. We will say yes or no. So those drugs will have had to have gone through a Health Canada review.

See context to find out what was said next.